Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: BEST SUPPORTIVE CARE, . Treffer: 15
2021
Müller, M; Posch, F; Kiem, D; Barth, D; Horvath, L; Stotz, M; Schaberl-Moser, R; Pichler, M; Greil, R; Jost, PJ; Seeber, A; Amann, A; Schlick, K; Gerger, A; Riedl, JM
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.
Ther Adv Med Oncol. 2021; 13: 17588359211039930
Doi: 10.1177/17588359211039930
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Smolle, MA; Leithner, A; Bernhardt, GA
Abdominal metastases of primary extremity soft tissue sarcoma: A systematic review.
World J Clin Oncol. 2020; 11(2): 74-82.
Doi: 10.5306/wjco.v11.i2.74
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2019
Barth, DA; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Stotz, M; Gerger, A
Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Clin Transl Oncol. 2019; 21(8):1034-1043
Doi: 10.1007/s12094-019-02037-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Scheithauer, W; Putora, PM; Grünberger, B; Eisterer, W; Wöll, E; Prager, G; Schaberl-Moser, R; Greil, R; Glatzer, M
Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine.
Therap Adv Gastroenterol. 2019; 12(5):1756284819877635-1756284819877635
Doi: 10.1177/1756284819877635
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Riedl, JM; Posch, F; Moik, F; Bezan, A; Szkandera, J; Smolle, MA; Kasparek, AK; Pichler, M; Stöger, H; Stotz, M; Gerger, A
Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting.
Oncotarget. 2017; 8(56):96048-96061
Doi: 10.18632/oncotarget.21647
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Partl, R; Fastner, G; Kaiser, J; Kronhuber, E; Cetin-Strohmer, K; Steffal, C; Böhmer-Breitfelder, B; Mayer, J; Avian, A; Berghold, A
KPS/LDH index: a simple tool for identifying patients with metastatic melanoma who are unlikely to benefit from palliative whole brain radiotherapy.
Support Care Cancer. 2016; 24(2):523-528
Doi: 10.1007/s00520-015-2793-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Pleyer, L; Germing, U; Sperr, WR; Linkesch, W; Burgstaller, S; Stauder, R; Girschikofsky, M; Schreder, M; Pfeilstocker, M; Lang, A; Sliwa, T; Geissler, D; Schlick, K; Placher-Sorko, G; Theiler, G; Thaler, J; Mitrovic, M; Neureiter, D; Valent, P; Greil, R
Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.
Leuk Res. 2014; 38(4):475-483
Doi: 10.1016/j.leukres.2014.01.006
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Partl, R; Richtig, E; Avian, A; Berghold, A; Kapp, KS
Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
Int J Radiat Oncol Biol Phys. 2013; 85(3):662-666
Doi: 10.1016/j.ijrobp.2012.06.009
Web of Science
PubMed
FullText
FullText_MUG
2011
Andreou, D; Ruppin, S; Fehlberg, S; Pink, D; Werner, M; Tunn, PU
Survival and prognostic factors in chondrosarcoma: results in 115 patients with long-term follow-up.
Acta Orthop. 2011; 82(6): 749-55.
Doi: 10.3109/17453674.2011.636668
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pinter, M; Sieghart, W; Hucke, F; Graziadei, I; Vogel, W; Maieron, A; Königsberg, R; Weissmann, A; Kornek, G; Matejka, J; Stauber, R; Buder, R; Grünberger, B; Schöniger-Hekele, M; Müller, C; Peck-Radosavljevic, M
Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib.
Aliment Pharmacol Ther. 2011; 34(8): 949-959.
Doi: 10.1111/j.1365-2036.2011.04823.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2010
Pircher, A; Ploner, F; Popper, H; Hilbe, W
Rationale of a relaunch of gefitinib in Caucasian non-small cell lung cancer patients.
Lung Cancer. 2010; 69(3): 265-271.
Doi: 10.1016/j.lungcan.2010.01.017
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2008
Stauder, R; Wimazal, F; Nösslinger, T; Krieger, O; Sperr, WR; Sill, H; Pfeilstöcker, M; Valent, P
Individualized management and therapy of myelodysplastic syndromes.
Wien Klin Wochenschr. 2008; 120(17-18): 523-537.
Doi: 10.1007/s00508-008-1058-6
Web of Science
PubMed
FullText
FullText_MUG
2007
Ploner, F
NSCLC: update on second line therapy following ASCO 2007
Wien Med Wochenschr. 2007; 157(21-22): 540-544.
Doi: 10.1007/s10354-007-0481-z
PubMed
FullText
FullText_MUG
2006
Ladurner, R; Hochleitner, B; Schneeberger, S; Barnas, U; Krismer, A; Kleinsasser, A; Offner, F; Königsrainer, I; Margreiter, R; Königsrainer, A
Extended liver resection and hepatic ischemia in pigs: a new, potentially reversible model to induce acute liver failure and study artificial liver support systems.
Eur Surg Res. 2006; 37(6):365-369
Doi: 10.1159/000090338
Web of Science
PubMed
FullText
FullText_MUG
2003
Ghofrani, HA; Schermuly, RT; Rose, F; Wiedemann, R; Kohstall, MG; Kreckel, A; Olschewski, H; Weissmann, N; Enke, B; Ghofrani, S; Seeger, W; Grimminger, F
Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension.
Am J Respir Crit Care Med. 2003; 167(8):1139-1141
Doi: 10.1164/rccm.200210-1157BC
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar